These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 18367314)
1. Re: Ching-Chia Li, Tu-Hao Chang, Wen-Jeng Wu, et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in taiwanese patients. Eur Urol 2008;54:1127-35. Chung SD; Yu HJ; Chueh SC Eur Urol; 2009 Apr; 55(4):e69-70; author reply e71. PubMed ID: 18367314 [No Abstract] [Full Text] [Related]
2. Editorial comment on: significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Sagalowsky AI Eur Urol; 2008 Nov; 54(5):1134-5. PubMed ID: 18243496 [No Abstract] [Full Text] [Related]
3. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511 [TBL] [Abstract][Full Text] [Related]
4. Radical laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: current status. Matin SF BJU Int; 2005 Mar; 95 Suppl 2():68-74. PubMed ID: 15720338 [No Abstract] [Full Text] [Related]
5. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy. Li WM; Li CC; Ke HL; Wu WJ; Huang CN; Huang CH J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379 [TBL] [Abstract][Full Text] [Related]
7. Re: Ricardo L. Favaretto, Shahrokh F. Shariat, Daher C. Chade et al. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 2010;58:574-80. Mouracade P Eur Urol; 2011 Apr; 59(4):e23. PubMed ID: 21255908 [No Abstract] [Full Text] [Related]
8. Re: Maurizio A. Brausi, Mirko Gavioli, Giuseppe De Luca et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Eur Urol 2007;52:1414-20. Simone G; Papalia R; Gallucci M Eur Urol; 2008 Aug; 54(2):467; author reply 468. PubMed ID: 18262332 [No Abstract] [Full Text] [Related]
9. The endoscopic approach to the distal ureter in nephroureterectomy for upper urinary tract tumor. Laguna MP; de la Rosette JJ J Urol; 2001 Dec; 166(6):2017-22. PubMed ID: 11696698 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma. Manabe D; Saika T; Ebara S; Uehara S; Nagai A; Fujita R; Irie S; Yamada D; Tsushima T; Nasu Y; Kumon H; Urology; 2007 Mar; 69(3):457-61. PubMed ID: 17382144 [TBL] [Abstract][Full Text] [Related]
11. Incidence of local recurrence and port site metastasis after laparoscopic radical nephroureterectomy. Muntener M; Schaeffer EM; Romero FR; Nielsen ME; Allaf ME; Brito FA; Pavlovich CP; Kavoussi LR; Jarrett TW Urology; 2007 Nov; 70(5):864-8. PubMed ID: 18068440 [TBL] [Abstract][Full Text] [Related]
12. Re: Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?: W. J. Wu, H. L. Ke, Y. H. Yang, C. C. Li, Y. H. Chou and C. H. Huang J Urol 2010; 183: 56-61. Mouracade P J Urol; 2010 Oct; 184(4):1571. PubMed ID: 20728904 [No Abstract] [Full Text] [Related]
13. Bladder cancer: Tumour recurrence after radical nephroureterectomy for UTUC. Ouzzane A; Colin P Nat Rev Urol; 2014 Jan; 11(1):15-6. PubMed ID: 24346009 [No Abstract] [Full Text] [Related]
14. Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised? Giannarini G; Schumacher MC; Thalmann GN; Bitton A; Fleischmann A; Studer UE BJU Int; 2007 Aug; 100(2):264-8. PubMed ID: 17532855 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery. Koda S; Mita K; Shigeta M; Usui T Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309 [TBL] [Abstract][Full Text] [Related]
16. Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy. Ishioka J; Saito K; Kijima T; Nakanishi Y; Yoshida S; Yokoyama M; Matsuoka Y; Numao N; Koga F; Masuda H; Fujii Y; Sakai Y; Arisawa C; Okuno T; Nagahama K; Kamata S; Sakura M; Yonese J; Morimoto S; Noro A; Tsujii T; Kitahara S; Gotoh S; Higashi Y; Kihara K BJU Int; 2015 May; 115(5):705-12. PubMed ID: 24612074 [TBL] [Abstract][Full Text] [Related]